Yale Cancer Center

A Comprehensive Cancer Center Designated by the National Cancer Institute

Yale Cancer Center

Search this site

Patient & Cancer Information
Research & Education
About Us
Make a Gift
News
Contact Us

Clinical Programs
Our Experts
Your Care
Supportive Care
Clinical Trials
Calendar
Cancer Answers

Brain Tumor
Breast Cancer
Endocrine Cancers
Gastrointestinal Cancers
Gynecologic Oncology
Head & Neck
Hematology
Melanoma
Pediatric Hematology & Oncology
Prostate and Urologic Cancers
Sarcoma
Thoracic Oncology

Find a Doctor

Find a Doctor

Join Our Mailing List

Friend Us
Subscribe to Podcasts

Print

Patient & Cancer Information | Our Experts | Expert Profiles

Salley G Pels MD

Instructor in Pediatrics (Hematology / Oncology); Associate Director, Yale Hemostasis Center

General Info
Bio
Research & Publications
Patient Care

Email

Contact Info

Appt: (203) 785-4640
Fax: (203) 737-2228

Research Organizations

Cancer Center, Yale

Pediatrics: Pediatric Hematology & Oncology

Research Keywords

Blood Coagulation Disorders
Blood Platelet Disorders
Hemorrhagic Disorders
Thrombophilia

Clinical Trials

A Phase II Study of Cixutumumab (IMC-A12; IND# 100947) in Combination with Temsirolimus (IND# 61010) in Pediatric Patients with Recurrent or Refractory Solid Tumors (ADVL1221)

© Yale School of Medicine

Yale School of Medicine
Contact Us
Intranet
Privacy policy
Site editor
Updated 10/07/11